Financial Data and Key Metrics Changes - The company expects consolidated net sales growth of 4% at the midpoint for fiscal 2026, reflecting confidence in its strategy and execution capabilities [8][10] - Inventory increased by $35 million or 48% to $107 million at the end of fiscal 2025, primarily driven by growth initiatives at Rise Wellness and Hiya [11] Business Line Data and Key Metrics Changes - Rise Wellness and Hiya are identified as key drivers of sales growth, with Rise expected to operate at approximately break-even in fiscal 2026 while supporting future growth [12] - The company is focusing on expanding its omni-channel reach and enhancing product innovation to drive sales momentum [8][9] Market Data and Key Metrics Changes - The company is diversifying its distribution channels to access a larger global base of health-conscious consumers, particularly through retail partnerships with major retailers like Target and Costco [24][33] - The core nutritional business is experiencing year-over-year sales declines but shows signs of stabilization [14] Company Strategy and Development Direction - The company aims to transition from a legacy Direct Selling business to a modern, science-driven nutritional products company [7] - Key strategic priorities include strengthening global brand positioning, enhancing customer experience, and improving operational efficiencies [6][8] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the evolving external environment and emphasizes the need for speed, focus, and precision in execution [6] - The company is committed to long-term strategic execution rather than short-term optimization, aiming to strengthen its foundation for future growth [8][14] Other Important Information - The effective income tax rate for fiscal 2026 is expected to range between 55% and 60%, influenced by geographic misalignment between revenue and costs [12] - The company plans to leverage technology modernization to improve customer experience and operational efficiencies [10][43] Q&A Session Summary Question: Can you walk us through the guidance for revenue and EPS? - Management discussed the potential for achieving the top end of guidance through improved macro conditions and specific brand performance [16][20] Question: What is the expected seasonality of the business? - Management indicated that seasonality is influenced by events like the Lunar New Year, with Q1 typically stronger due to promotional activities [33][35] Question: How much did the cost realignment impact headcount and what are the implications for gross margins? - Approximately 10% of the workforce was impacted, resulting in about $10 million in savings, with expectations for gross margins to be affected by the mix of different businesses [39][41] Question: What are the company's thoughts on integrating technology into consumer health management? - Management expressed interest in utilizing technology to personalize nutrition and enhance consumer engagement, emphasizing the importance of staying relevant in the market [50][52]

Financial Data and Key Metrics Changes - The consolidated net sales outlook for fiscal 2026 is projected to grow by 4% at the midpoint, reflecting confidence in the company's strategy and execution capabilities [12][16] - Inventory increased by $35 million or 48% to $107 million at the end of fiscal 2025, primarily driven by growth initiatives at Rise Wellness and Hiya [18][20] - The effective income tax rate for fiscal 2026 is expected to range between 55% and 60%, influenced by geographic misalignment between revenue and costs [22] Business Line Data and Key Metrics Changes - Sales growth is being driven by venture companies, specifically Rise Wellness and Hiya, with significant inventory buildup to support their growth [16][20] - Rise Wellness is expected to operate at approximately break-even in fiscal 2026 while positioning for future growth [21] Market Data and Key Metrics Changes - The company is focusing on expanding its omni-channel reach to access a larger global base of health-conscious consumers [12][14] - The company is diversifying its distribution channels to strengthen brand relevance and drive sales momentum [10][14] Company Strategy and Development Direction - The company aims to transition from a legacy Direct Selling business to a modern, science-driven nutritional products company [10] - Key strategic priorities include enhancing customer experience, advancing product innovation, and improving operational efficiencies [11][12] - The company is committed to leveraging technology modernization to improve customer experience and drive long-term efficiencies [13][14] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the evolving external environment but emphasizes strong underlying fundamentals and growth opportunities [9][24] - The company is focused on long-term strategic execution rather than short-term optimization, aiming to strengthen its foundation for future growth [12][24] Other Important Information - The company is investing in technology to enhance brand interaction and leverage AI for better customer engagement [54][55] - Management is optimistic about the health and wellness market, projecting a global CAGR of 5%-8% [55] Q&A Session Summary Question: Guidance for revenue and EPS - Management discussed the wide range in revenue guidance, attributing it to various factors including macroeconomic conditions and brand performance [27][28] Question: Seasonality of the business - Management noted that seasonality impacts revenue, particularly around the Lunar New Year, with Q1 typically seeing stronger sales [44][46] Question: Cost realignment and headcount reduction - The company reduced about 10% of its workforce, resulting in approximately $10 million in savings, which will be repurposed for strategic initiatives [50] Question: Technology initiatives - Management highlighted the importance of leveraging technology to stay relevant and improve customer interaction with the brand [53][54] Question: Personalization in health management - The company is exploring ways to personalize nutrition and health monitoring while ensuring scientific integrity in its offerings [65]

Financial Data and Key Metrics Changes - The consolidated net sales outlook for fiscal 2026 is projected to grow by 4% at the midpoint, reflecting confidence in the company's strategy and execution capabilities [8][10] - Inventory increased by $35 million or 48% to $107 million at the end of fiscal 2025, primarily driven by growth initiatives at Rise Wellness and Hiya [11] Business Line Data and Key Metrics Changes - Rise Wellness and Hiya are expected to drive sales growth, with Rise Wellness anticipated to operate at approximately break-even in fiscal 2026 while supporting future growth [12] - The company is focusing on expanding its omni-channel reach and enhancing product innovation to support these brands [8][9] Market Data and Key Metrics Changes - The company is diversifying its distribution channels to access a larger global base of health-conscious consumers, particularly through retail expansions in Target and Costco [24][25] - The company is also entering new markets, including Canada and the United Kingdom, for Hiya products [11][24] Company Strategy and Development Direction - The company aims to transition from a legacy Direct Selling business to a modern, science-driven nutritional products company [6] - Key strategic priorities include strengthening global brand positioning, enhancing customer experience, reinvigorating sales momentum, advancing product innovation, and improving operational efficiencies [6][7] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the evolving external environment but believes the company is well-positioned with strong fundamentals and growth opportunities [5][14] - The company emphasizes the importance of speed, focus, and precision in executing its strategic plans to drive sustainable growth [5][6] Other Important Information - The effective income tax rate for fiscal 2026 is expected to range between 55% and 60%, influenced by geographic misalignment between revenue and costs [12] - The company is committed to leveraging technology and AI to enhance customer interactions and improve operational efficiencies [44][45] Q&A Session Summary Question: Can you walk us through the guidance for revenue and EPS? - Management discussed the potential for revenue growth driven by Rise Wellness and Hiya, emphasizing the importance of achieving top-line growth to reach the upper end of EPS guidance [17][19] Question: What is the expected seasonality of the business? - Management indicated that seasonality is influenced by events like the Lunar New Year, with Q1 typically seeing stronger sales due to promotional activities [35][36] Question: How much did the cost realignment lower headcount and what are the implications for gross margins? - The cost realignment impacted about 10% of the workforce, resulting in approximately $10 million in savings, which will primarily affect SG&A rather than gross margins [40][41] Question: What are the company's thoughts on integrating technology into consumer health management? - Management expressed interest in utilizing technology to personalize nutrition and enhance consumer engagement, while ensuring scientific integrity in product offerings [52][54]

Core Viewpoint - USANA Health Sciences, Inc. has announced preliminary fiscal year 2025 net sales of approximately $925 million, exceeding previous guidance, and provided initial net sales guidance for fiscal year 2026 in the range of $925 million to $1.0 billion [2][3]. Fiscal Year 2025 Net Sales Results - The company anticipates consolidated net sales for fiscal year 2025 to be around $925 million, which is an increase from the previously issued guidance of approximately $920 million [2]. Initial Fiscal Year 2026 Net Sales Outlook - The initial net sales outlook for fiscal year 2026 is projected to be between $925 million and $1.0 billion, driven by significant growth in the Rise Wellness segment, which includes Rise Bar and Protein Pop [3]. - Rise Wellness is expected to achieve breakeven operating margins in fiscal 2026 as the company invests in strategic initiatives for future growth [3]. Investments in Growth - The company is making substantial investments in inventory, capital expenditures, and working capital for both Rise Wellness and Hiya to support their early growth stages [4]. Participation in ICR Conference - USANA will participate in the 28th Annual ICR Conference on January 12-13, 2026, where key executives will present the company's strategy and sales outlook [5]. Fourth Quarter and Fiscal Year 2025 Earnings Release - Preliminary financial results and the initial fiscal 2026 sales outlook will be updated during the earnings release scheduled for February 17, 2026, followed by a conference call on February 18, 2026 [6]. Segment-Specific Net Sales Projections for Fiscal Year 2026 - Projected net sales for fiscal year 2026 include: - Core nutritional business: $720 to $765 million (down from approximately $777 million in fiscal 2025) - Hiya: $140 to $155 million (up from approximately $132 million in fiscal 2025) - Rise Wellness: $65 to $80 million (up from approximately $16 million in fiscal 2025) [8].